EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TNC Accelerates Hypoxia-Induced Cardiac Injury in a METTL3-Dependent Manner

Hao Cheng iD, Linnan Li, Junqiang Xue, Jianying Ma, Junbo Ge

Genes · 26.02.2023 · 14 (3) · 591

DOI: 10.3390/genes14030591 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, online erschienen am 26.02.2023. Verfasst von Hao Cheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China. Hauptthemen laut MEDLINE: Heart Injuries, Methyltransferases, Myocardial Infarction, Tenascin. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major Research Plan of the National Natural Science Foundation of China, Nation Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiac fibrosis and cardiomyocyte apoptosis are reparative processes after myocardial infarction (MI), which results in cardiac remodeling and heart failure at last. Tenascin-C (TNC) consists of four distinct domains, which is a large multimodular glycoprotein of the extracellular matrix. It is also a key regulator of proliferation and apoptosis in cardiomyocytes. As a significant m6A regulator, METTL3 binds m6A sites in mRNA to control its degradation, maturation, stabilization, and translation. Whether METTL3 regulates the occurrence and development of myocardial infarction through the m6A modification of TNC mRNA deserves our study. Here, we have demonstrated that overexpression of METTL3 aggravated cardiac dysfunction and cardiac fibrosis after 4 weeks after MI. Moreover, we also demonstrated that TNC resulted in cardiac fibrosis and cardiomyocyte apoptosis after MI. Mechanistically, METTL3 led to enhanced m6A levels of TNC mRNA and promoted TNC mRNA stability. Then, we mutated one m6A site “A” to “T”, and the binding ability of METTL3 was reduced. In conclusion, METTL3 is involved in cardiac fibrosis and cardiomyocyte apoptosis by increasing m6A levels of TNC mRNA and may be a promising target for the therapy of cardiac fibrosis after MI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart InjuriesMethyltransferasesMyocardial InfarctionTenascinExtracellular MatrixFibrosisHypoxiaMyocytes, CardiacRNA, MessengerMiceAnimals

Stichwörter der Autor:innen

METTL3TNCmyocardial infarction

Substanzen

MethyltransferasesRNA, MessengerTenascinMettl3 protein, mouse

Autor:innen und Institutionen

  • Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Shanghai Institute of Cardiovascular Diseases, Shanghai 200032, China.

ORCID-Profile: Hao Cheng

Förderung

  • Major Research Plan of the National Natural Science Foundation of China
  • Nation Natural Science Foundation of China

Zitieren

APA

Cheng, H., Li, L., Xue, J., Ma, J., & Ge, J. (2023). TNC Accelerates Hypoxia-Induced Cardiac Injury in a METTL3-Dependent Manner. Genes, 14(3), 591. https://doi.org/10.3390/genes14030591

Vancouver

Cheng H, Li L, Xue J, Ma J, Ge J. TNC Accelerates Hypoxia-Induced Cardiac Injury in a METTL3-Dependent Manner. Genes. 2023;14(3):591. doi:10.3390/genes14030591

BibTeX
@article{Cheng2023,
  author = {Cheng, Hao and Li, Linnan and Xue, Junqiang and Ma, Jianying and Ge, Junbo},
  title = {TNC Accelerates Hypoxia-Induced Cardiac Injury in a METTL3-Dependent Manner},
  journal = {Genes},
  year = {2023},
  volume = {14},
  number = {3},
  pages = {591},
  doi = {10.3390/genes14030591}
}
Kostenlos starten →